Altrecht Psychiatric Institute, ABC-straat 8, 3512 PX Utrecht, The Netherlands.
J Behav Ther Exp Psychiatry. 2013 Sep;44(3):300-6. doi: 10.1016/j.jbtep.2013.01.004. Epub 2013 Feb 1.
The treatment of negative symptoms in schizophrenia is a major challenge for mental health care. One randomized controlled trial found that cognitive therapy for low-functioning patients reduced avolition and improved functioning, using an average of 50.5 treatment sessions over the course of 18 months. The aim of our current pilot study was to evaluate whether 20 sessions of Cognitive Behavioral Therapy for negative symptoms (CBT-n) would reduce negative symptoms within 6 months. Also, we wanted to test the cognitive model of negative symptoms by analyzing whether a reduction in dysfunctional beliefs mediated the effects on negative symptoms.
In an open trial 21 adult outpatients with a schizophrenia spectrum disorder with negative symptoms received an average of 17.5 sessions of CBT-n. At baseline and end-of-treatment, we assessed negative symptoms (PANSS) and dysfunctional beliefs about cognitive abilities, performance, emotional experience, and social exclusion. Bootstrap analysis tested mediation.
The dropout rate was 14% (three participants). Intention-to-treat analyses showed a within group effect size of 1.26 on negative symptoms (t = 6.16, | Sig = 0.000). Bootstrap analysis showed that dysfunctional beliefs partially mediated the change.
The uncontrolled design induced efficacy biases. Also, the sample was relatively small, and there were no follow-up assessments.
CBT-n may be effective in reducing negative symptoms. Also, patients reported fewer dysfunctional beliefs about their cognitive abilities, performance, emotional experience, and social exclusion, and this reduction partially mediated the change in negative symptoms. The reductions were clinically important. However, larger and controlled trials are needed.
精神分裂症阴性症状的治疗是精神卫生保健的一大挑战。一项随机对照试验发现,认知疗法对低功能患者减少意志减退和改善功能有效,在 18 个月的过程中平均使用 50.5 次治疗。我们当前的初步研究旨在评估 20 次消极症状认知行为治疗(CBT-n)是否会在 6 个月内减少消极症状。此外,我们希望通过分析功能失调信念的减少是否对消极症状的影响进行中介,来检验消极症状的认知模型。
在一项开放试验中,21 名成年门诊精神分裂症谱系障碍伴阴性症状的患者接受了平均 17.5 次 CBT-n。在基线和治疗结束时,我们评估了阴性症状(PANSS)和对认知能力、表现、情绪体验和社会排斥的功能失调信念。使用自举分析测试中介。
辍学率为 14%(3 名参与者)。意向性治疗分析显示,阴性症状的组内效应大小为 1.26(t = 6.16,|Sig = 0.000)。自举分析表明,功能失调信念部分介导了变化。
非控制设计导致疗效偏见。此外,样本相对较小,且没有随访评估。
CBT-n 可能有效减少阴性症状。此外,患者报告的认知能力、表现、情绪体验和社会排斥的功能失调信念减少,这种减少部分中介了阴性症状的变化。这些减少具有临床意义。然而,需要更大规模和对照试验。